Facts
The Petitioner, Glaxo Group Limited (part of GlaxoSmithKline), sought the cancellation of Respondent No. 1’s registration for the trademark ‘PAXIL’ under Class 5
Source reference: p. 1-2The Petitioner established global use and registration of the mark since 1991
Source reference: p. 2Respondent No. 1 had acquired the mark from Rallis India (who registered it in 1973) and obtained a fresh registration in April 2005
Source reference: p. 13-14The Petitioner alleged that Respondent No. 1 had not used the mark for over 20 years since registration
Source reference: p. 3Respondent No. 1 admitted to non-use, justifying it as a commercial decision for "expansion of business" and challenged the Petitioner's status as a "person aggrieved"
Source reference: p. 8, 10Issues
1. Whether the Petitioner qualifies as a "person aggrieved" under Section 47 of the Trade Marks Act, 1999, despite having no commercial use of the mark in India.
Source reference: p. 4 / para. 30(E)2. Whether Respondent No. 1’s non-use of the mark is protected by the "special circumstances in the trade" exception under Section 47(3).
Source reference: p. 8 / para. 30(B)3. Whether the impugned registration is liable to be removed on grounds of non-use and "squatting."
Source reference: p. 7 / para. 30(D)Law Applied
The court applied Section 47 of the Trade Marks Act, 1999, which mandates the removal of a mark for non-use for a continuous period of five years
Source reference: p. 22It relied on Hardie Trading Ltd. v. Addisons Paint Chemicals Ltd., which defined "person aggrieved" liberally to include those whose legal rights are limited by the mark's presence
Source reference: p. 4-5The "special circumstances" exception under Section 47(3) was interpreted through Aktiebolaget Jonkoping Vulcan v. VSV Palanichamy, holding that such circumstances must be external, industry-wide, and not personal commercial decisions
Source reference: p. 9, 24The court also cited Neon Laboratories v. Medical Technologies regarding the legislative intent to prevent trademark hoarding/squatting
Source reference: p. 7Reasoning
The court found that the Petitioner is a "person aggrieved" because the impugned registration creates a practical barrier to the Petitioner registering its own globally recognized mark in India
Source reference: para. 30(E)-(F)The court rejected Respondent No. 1’s "territoriality" defense, noting that Section 47 does not require an applicant to prove Indian goodwill, only a genuine interest in the register's purity
Source reference: para. 30(G)Regarding non-use, the court held that Respondent No. 1’s justification—"expansion of business"—was a voluntary, internal commercial strategy and not a "special circumstance in the trade" (which requires external factors like import duty or war)
Source reference: para. 30(B)-(C)Consequently, the mark’s presence on the register for 20% years without use constituted "squatting," which violates the fundamental purpose of trademark law to serve as a source identifier
Source reference: para. 30(D)Holding
The court allowed the Petition, holding that Respondent No. 1 had no bona fide intention to use the mark and had failed to demonstrate special circumstances justifying 20 years of non-use
The court directed the removal of Respondent No. 1’s registration for ‘PAXIL’ (No. 1153709) from the Register of Trade Marks
Source reference: p. 28Acts & Sections Cited
2 provisions across 1 statute referred to in this judgment. Each provision opens on LawLens.
Trade Marks Act, 19992
Original Court PDF
Glaxo Group LimitedvsShreya Life Sciences Private Limited
Click to open original judgment
Original judgment, available to read, download and summarize on LawLens.in
